Aditxt (ADTX) Revenue & Revenue Breakdown
Aditxt Revenue Highlights
Latest Revenue (Y)
$133.99M
Latest Revenue (Q)
$748.00
Aditxt Revenue by Period
Aditxt Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $133.99M | 20667.20% |
| 2023-12-31 | $645.18K | -30.90% |
| 2022-12-31 | $933.72K | 788.96% |
| 2021-12-31 | $105.03K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Aditxt generated $133.99M in revenue during NA 2024, up 20667.20% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Aditxt Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $748.00 | -25.50% |
| 2025-06-30 | $1.00K | -1.38% |
| 2025-03-31 | $1.02K | -67.94% |
| 2024-12-31 | $3.17K | -53.68% |
| 2024-09-30 | $6.85K | -84.52% |
| 2024-06-30 | $44.28K | -44.43% |
| 2024-03-31 | $79.68K | -1.99% |
| 2023-12-31 | $81.30K | -34.69% |
| 2023-09-30 | $124.49K | -43.67% |
| 2023-06-30 | $220.98K | 1.17% |
| 2023-03-31 | $218.41K | 17.68% |
| 2022-12-31 | $185.60K | -42.56% |
| 2022-09-30 | $323.13K | 50.49% |
| 2022-06-30 | $214.72K | 2.11% |
| 2022-03-31 | $210.28K | 100.20% |
| 2021-12-31 | $105.03K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | - |
Aditxt generated $748.00 in revenue during Q3 2025, up -25.50% compared to the previous quarter, and up 1.69% compared to the same period a year ago.
Aditxt Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADTX | Aditxt | $133.99M | $748.00 |
| ANL | Adlai Nortye | $5.00M | $2.50M |
| BLRX | BioLineRx | $4.80M | $6.86M |
| ICU | SeaStar Medical | $135.00K | $338.00K |
| GOVX | GeoVax Labs | - | $852.28K |
| APLM | Apollomics | - | - |
| CTXR | Citius Pharmaceuticals | - | - |
| AIMD | Ainos | - | $4.66K |
| MBRX | Moleculin Biotech | - | - |
| THAR | Tharimmune | - | - |
| ATHA | Athira Pharma | - | - |